Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Jun 15;185(12):1329-30.
doi: 10.1164/ajrccm.185.12.1329.

Plasma proteins for risk prediction in idiopathic pulmonary fibrosis

Thomas J Richards, Naftali Kaminski, Kevin F Gibson
Comment

Plasma proteins for risk prediction in idiopathic pulmonary fibrosis

Thomas J Richards et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Outcome prediction based on personalized clinical and molecular mortality index (PCMI). Panel A was originally published as Figure 4A in Reference 2. (A) PCMI predicts mortality in idiopathic pulmonary fibrosis. Solid lines show published mortality curves. Red line shows PCMI ≥ 330; black line shows PCMI < 330. Median survival after blood draw was 5.2 and 1.6 years, respectively. (B) Survival curves for mortality with lung transplant as a competing risk. Broken lines are survival curves; solid lines are confidence intervals on the medians from data in Figure 4A; red line shows PCMI ≥ 330; black line shows PCMI < 330 (hazard ratio = 4.37, P = 0.0018). Estimated medians are comfortably within confidence intervals from published analysis.
See this image and copyright information in PMC

Comment on

References

    1. Ley B, Collard HR. Risk prediction in idiopathic pulmonary fibrosis [editorial]. Am J Respir Crit Care Med 2012;185:6–7. - PubMed
    1. Richards TJ, Kaminski N, Baribaud F, Flavin S, Brodmerkel C, Horowitz D, Li K, Choi J, Vuga LJ, Lindell KO, et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012;185:67–76. - PMC - PubMed
    1. du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Raghu G, Sahn SA, et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;184:459–466. - PubMed
    1. Collard HR, Calfee CS, Wolters PJ, Song JW, Hong SB, Brady S, Ishizaka A, Jones KD, King TE, Matthay MA, et al. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2010;299:L3–L7. - PMC - PubMed
    1. Kinder BW, Brown KK, McCormack FX, Ix JH, Kervitsky A, Schwarz MI, King TE. Serum surfactant protein-a is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 2009;135:1557–1563. - PMC - PubMed